,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2021_Human,Staphylococcus aureus infection,24/95,1.6515387381582038e-07,4.855523890185118e-05,0,0,4.07407065342877,63.62226899647021,DEFA5;KRT24;KRT35;KRT13;KRT23;KRT34;KRT32;KRT10;KRT31;KRT9;KRT33B;KRT33A;KRT19;KRT17;KRT38;KRT16;KRT37;KRT15;KRT25;KRT36;KRT14;DSG1;DEFB4A;MBL2
1,KEGG_2021_Human,Estrogen signaling pathway,29/137,5.428504045641432e-07,7.979900947092906e-05,0,0,3.2404178849902534,46.747668441167946,CALML5;KRT24;KRT23;CALML3;ADCY2;ADCY8;GRM1;KRT33B;KRT33A;KRT25;HRAS;KCNJ9;KRT35;KRT13;KRT34;KRT32;KRT10;KRT31;KRT9;POMC;KRT19;KRT17;KRT38;KRT16;KRT37;KRT15;KRT36;KRT14;FKBP4
2,KEGG_2021_Human,Nicotine addiction,14/40,8.951289346531139e-07,8.772263559600516e-05,0,0,6.463292407917815,90.00973657319133,GABRQ;GABRA1;CHRNA4;GABRA5;CHRNA7;GABRA4;CHRNA6;GABRA3;CACNA1B;GABRG3;GABRG2;GABRR1;SLC17A7;GABRE
3,KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,19/76,3.7117883970457753e-06,0.00027281644718286447,0,0,4.007407407407407,50.10860919723196,GSTM4;UGT1A10;GSTM3;GSTM2;GSTM1;UGT1A1;UGT2B17;ADH7;ALDH3A1;ALDH3B2;CYP2S1;GSTA1;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7;SULT2A1;GSTM5
4,KEGG_2021_Human,Neuroactive ligand-receptor interaction,50/341,9.242697141411595e-06,0.0005434705919150018,0,0,2.0815709900529336,24.12889818726134,CHRM3;HTR2C;ADM;ADRA1D;TRH;GRM1;LTB4R;MC4R;GHR;GABRR1;HTR7;UCN2;GHSR;CHRNB4;EDN3;PTH2R;SSTR2;GABRG3;ADRA2B;GABRG2;SSTR4;CCKBR;CHRNA4;CHRNA7;CHRNA6;LPAR3;GPR83;NTS;MCHR2;NPBWR1;NPY;PENK;P2RY1;GABRE;GPR156;DRD2;S1PR5;GABRQ;GABRA1;SLURP2;HTR1E;GABRA5;GABRA4;GCGR;GABRA3;GPR50;SLURP1;POMC;GHRH;F2RL2
5,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,27/143,1.2698459690968451e-05,0.0006222245248574542,0,0,2.803961439122751,31.61194497982944,WNT2B;DLX5;FZD10;SOX2;WNT6;ACVR1C;WNT11;DVL3;HOXA1;OTX1;HRAS;WNT10B;WNT3A;FZD7;WNT7B;ESX1;WNT5A;ESRRB;FZD6;PAX6;KLF4;DUSP9;MAPK12;LHX5;FGFR3;NEUROG1;FGFR2
6,KEGG_2021_Human,Basal cell carcinoma,16/63,1.7256673986048845e-05,0.0007247803074140515,0,0,4.086882902388586,44.822118228757944,WNT10B;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;LEF1;FZD6;FZD10;GLI1;KIF7;GLI2;WNT6;WNT11;SMO;DVL3
7,KEGG_2021_Human,Bile secretion,19/90,4.910165437935853e-05,0.0018044857984414,0,0,3.2147657184939704,31.895676870759974,UGT1A10;ABCG8;ABCG5;UGT1A1;SLC22A1;SLC2A1;UGT2B17;ATP1B3;ADCY2;ADCY8;SLC9A3;SLCO1A2;UGT1A4;UGT2A1;UGT1A9;UGT1A8;SLC22A7;UGT1A7;SULT2A1
8,KEGG_2021_Human,Drug metabolism,21/108,7.243995871083724e-05,0.002366371984554,0,0,2.900974905217548,27.654275765432104,GSTM4;UGT1A10;GSTM3;GSTM2;GSTM1;UGT1A1;GMPS;UGT2B17;FMO1;FMO3;ADH7;ALDH3A1;ALDH3B2;UCK2;GSTA1;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7;GSTM5
9,KEGG_2021_Human,Cell adhesion molecules,24/148,0.0004303778516309962,0.0126531088379512,0,0,2.326007403490217,18.028527529524293,NLGN4Y;CNTNAP2;NLGN1;NRXN1;LRRC4;CD8B2;NRXN2;VTCN1;CLDN1;SELE;IGSF11;CLDN11;CLDN20;CDH3;CLDN8;CLDN24;CNTN1;CLDN19;CNTN2;NRCAM;CLDN17;ITGA6;CLDN16;NECTIN1
10,KEGG_2021_Human,Retinol metabolism,14/68,0.0006111637103540573,0.0159678562307331,0,0,3.107226444685728,22.993928402056383,UGT1A10;UGT1A1;UGT2B17;ADH7;CYP26A1;CYP2W1;RDH12;CYP2S1;RDH16;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
11,KEGG_2021_Human,Melanogenesis,18/101,0.0006981288727873402,0.0159678562307331,0,0,2.6018430351058055,18.907871318958783,WNT10B;WNT2B;CALML5;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;CALML3;ADCY2;FZD10;ADCY8;POMC;WNT6;WNT11;DVL3;HRAS
12,KEGG_2021_Human,Pathways in cancer,62/531,0.0007688668585298216,0.0159678562307331,0,0,1.5986223173688672,11.463069581808714,WNT2B;CALML5;EPO;SLC2A1;CALML3;LAMC2;FZD10;GLI1;FGF3;GLI2;FGF4;GNGT1;FGF8;CCND2;HEY1;SKP2;HRAS;DCC;MMP1;WNT5A;KIF7;PGF;CCNA1;SMO;COL4A6;BIRC5;COL4A5;ITGA6;NOTCH3;LAMA1;LEF1;ADCY2;LPAR3;ADCY8;PLD1;WNT6;WNT11;FGF20;DVL3;IL12RB2;GSTM4;JAG2;GSTM3;WNT10B;GSTM2;GSTM1;JAG1;JUP;NOS2;WNT3A;FZD7;WNT7B;FZD6;LAMB4;CDK6;RAD51;LPAR5;FGF19;GSTA1;FGFR3;FGFR2;GSTM5
13,KEGG_2021_Human,Hippo signaling pathway,25/163,0.000772903836878692,0.0159678562307331,0,0,2.176884818745483,15.598154522287505,WNT2B;LEF1;PARD6G;FZD10;GLI2;SOX2;WNT6;CCND2;WNT11;DVL3;WNT10B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;BMP7;FRMD1;DLG1;FRMD6;PPP2R2C;PPP2R2B;SNAI2;BIRC5;TP73
14,KEGG_2021_Human,Chemical carcinogenesis,33/239,0.0008535586068512056,0.0159678562307331,0,0,1.9279305530650408,13.622943047141188,UGT1A10;CHRNA4;CHRNA7;CACNA1B;ADCY2;ADCY8;FGF3;FGF4;FGF8;EIF4EBP1;FGF20;UGT1A4;UGT2A1;UGT1A9;HRAS;UGT1A8;UGT1A7;SULT2A1;GSTM4;GSTM3;GSTM2;CHRNB4;GSTM1;JAG1;UGT1A1;UGT2B17;KLF4;CDC25A;KLF5;GSTA1;BIRC5;AIPL1;GSTM5
15,KEGG_2021_Human,Pentose and glucuronate interconversions,9/34,0.0008689989785433007,0.0159678562307331,0,0,4.307376623376624,30.359116700314075,UGT1A10;AKR1B10;UGT1A1;UGT1A4;UGT2B17;UGT2A1;UGT1A9;UGT1A8;UGT1A7
16,KEGG_2021_Human,Breast cancer,23/147,0.0009326059051506914,0.0161285962420178,0,0,2.227629687566059,15.543348165962582,JAG2;NOTCH3;WNT10B;JAG1;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;FZD10;FGF3;FGF4;WNT6;FGF8;CDK6;WNT11;HEY1;FGF19;FGF20;DVL3;HRAS
17,KEGG_2021_Human,GABAergic synapse,16/89,0.0012285029425593,0.0200655480618021,0,0,2.627563466745302,17.609822547195527,GABRQ;GABRA1;GABRA5;GABRA4;GABRA3;CACNA1B;GAD2;SLC6A11;ADCY2;ADCY8;GABRG3;GABRG2;GNGT1;GABRR1;HAP1;GABRE
18,KEGG_2021_Human,Ascorbate and aldarate metabolism,8/30,0.0015891146077486,0.0245894576146372,0,0,4.348769984071736,28.02598853327684,UGT1A10;UGT1A1;UGT1A4;UGT2B17;UGT2A1;UGT1A9;UGT1A8;UGT1A7
19,KEGG_2021_Human,Gastric acid secretion,14/76,0.0019068794514567,0.0277049970244267,0,0,2.7051171587685197,16.94022047148484,CHRM3;CALML5;KCNJ16;CALML3;ATP1B3;ADCY2;SSTR2;ADCY8;ATP4B;ATP4A;SLC9A4;CCKBR;GAST;KCNK2
20,KEGG_2021_Human,Salivary secretion,16/93,0.0019789283588876,0.0277049970244267,0,0,2.490524478782796,15.504012521284436,CHRM3;CALML5;ADRA1D;CALML3;ATP1B3;ADCY2;BEST2;ADCY8;STATH;HTN1;RYR3;HTN3;TRPV6;MUC7;PRKG2;NOS1
21,KEGG_2021_Human,Steroid hormone biosynthesis,12/61,0.0022099227752688,0.029532604360411,0,0,2.932083438450201,17.929097087282944,UGT1A10;UGT1A1;SULT1E1;HSD17B1;HSD17B3;AKR1C3;UGT2B17;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
22,KEGG_2021_Human,Porphyrin and chlorophyll metabolism,9/43,0.0049743675046253,0.0635853933199939,0,0,3.1656417112299464,16.788844855003383,UGT1A10;HEPHL1;UGT1A1;UGT1A4;UGT2B17;UGT2A1;UGT1A9;UGT1A8;UGT1A7
23,KEGG_2021_Human,Cushing syndrome,21/155,0.0085189684525262,0.1043573635434467,0,0,1.8786483160115652,8.952623439936605,WNT10B;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;KCNA4;ADCY2;FZD10;ADCY8;NR5A1;POMC;WNT6;CDK6;WNT11;STAR;DVL3;AIPL1;KCNK2
24,KEGG_2021_Human,Morphine addiction,14/91,0.0100513063729984,0.1182033629464619,0,0,2.176369558779982,10.01141459011308,GABRQ;GABRA1;GABRA5;KCNJ9;GABRA4;GABRA3;CACNA1B;ADCY2;ADCY8;GABRG3;GABRG2;GNGT1;GABRR1;GABRE
25,KEGG_2021_Human,Hepatocellular carcinoma,22/168,0.0106133881392974,0.1198252972688748,0,0,1.8063442509711043,8.210988951967588,GSTM4;GSTM3;WNT10B;GSTM2;GSTM1;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;ACTL6A;LEF1;FZD10;WNT6;CDK6;WNT11;DPF1;GSTA1;DVL3;HRAS;GSTM5
26,KEGG_2021_Human,Gastric cancer,20/149,0.0111166524290935,0.1198252972688748,0,0,1.8578287475727664,8.358949461322291,WNT10B;WNT2B;JUP;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;FZD10;FGF3;FGF4;WNT6;FGF8;WNT11;FGF19;FGF20;DVL3;HRAS;FGFR2
27,KEGG_2021_Human,Glutathione metabolism,10/57,0.0114119330732261,0.1198252972688748,0,0,2.5443435223203794,11.381092095079556,GSTM4;GSTM3;GPX2;GSTM2;GCLC;GSTM1;GSTA1;CHAC2;GCLM;GSTM5
28,KEGG_2021_Human,Amoebiasis,15/102,0.0118227682085545,0.1198584087350013,0,0,2.0640201411680077,9.159560174107822,SERPINB3;SERPINB10;SERPINB4;SERPINB13;NOS2;ARG1;LAMA1;IL1R2;LAMB4;HSPB1;CXCL1;LAMC2;C9;COL4A6;COL4A5
29,KEGG_2021_Human,Cytokine-cytokine receptor interaction,34/295,0.0129564460378578,0.1269731711710071,0,0,1.5640782469051502,6.797737208894933,CNTFR;CXCL6;IL1RN;IL20;IL25;EPO;IL24;IL20RB;CXCL1;IL1RAP;CXCL13;GHR;IL36A;ACVR1C;IL36B;IL36RN;IL12RB2;TNFSF18;NGFR;IL11;IL31;TSLP;CD70;IL1R2;TNFRSF18;IL36G;IL19;BMP7;IL1F10;EDAR;IL1A;XCL1;ACKR3;CCL26
30,KEGG_2021_Human,Taste transduction,13/86,0.0147632982972364,0.1400132161092742,0,0,2.1307255993150687,8.982310323250605,CHRM3;GABRA1;HTR1E;GABRA5;GABRA4;GABRA3;HTR3C;ADCY8;GRM1;CALHM1;GNAT3;P2RY1;TAS1R2
31,KEGG_2021_Human,Arachidonic acid metabolism,10/61,0.0180299359334132,0.1656500363882343,0,0,2.3442775420759596,9.413966419491535,PLA2G2F;GPX2;PLA2G4B;CYP4F2;ALOX15;CYP4F3;AKR1C3;PLA2G3;ALOX12;ALOX12B
32,KEGG_2021_Human,PPAR signaling pathway,11/74,0.0265777289070011,0.2367834029896461,0,0,2.08751831898776,7.572851947899973,FABP4;HMGCS1;FABP5;MMP1;FABP7;SCD5;ME1;APOA2;UCP1;APOA1;SLC27A6
33,KEGG_2021_Human,Protein digestion and absorption,14/103,0.0274794724114515,0.2376166143813755,0,0,1.8816967390110897,6.763412716522782,COL17A1;CPA2;COL26A1;MME;COL22A1;ATP1B3;COL19A1;SLC9A3;SLC7A8;COL7A1;COL4A6;COL9A1;COL4A5;COL9A3
34,KEGG_2021_Human,IL-17 signaling pathway,13/94,0.028970060596736,0.2404067032862493,0,0,1.9194476594650205,6.797709251160179,CXCL6;IL25;MMP1;MMP3;CXCL1;MAPK12;S100A7A;MMP13;DEFB4A;MAPK6;S100A9;S100A8;S100A7
35,KEGG_2021_Human,Galactose metabolism,6/31,0.0294375555044387,0.2404067032862493,0,0,2.86600129617628,10.104041775858663,MGAM2;AKR1B10;PGM2;LALBA;HK2;GCK
36,KEGG_2021_Human,Alcoholism,22/186,0.0308151390246918,0.244855429007011,0,0,1.606505662306132,5.590236765873133,H2BC9;H3C8;NTRK2;H2AC8;CALML5;H2BC3;CALML3;MACROH2A2;H2AC11;GNGT1;H2AC12;H3C15;NPY;H2BC11;H3C1;H4C2;H4C1;DRD2;H2BW1;H2BW2;HRAS;H3C7
37,KEGG_2021_Human,Calcium signaling pathway,27/240,0.0322872314533263,0.2498012117704724,0,0,1.5189613370102348,5.214721008979357,CHRM3;CALML5;CHRNA7;CACNA1B;HTR2C;CALML3;ADCY2;ADRA1D;ADCY8;RYR3;FGF3;GRM1;FGF4;HTR7;FGF8;FGF20;NOS1;NTRK2;NOS2;SPHK1;TRDN;CCKBR;GDNF;FGF19;PPIF;FGFR3;FGFR2
38,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,11/77,0.0344657702718502,0.2598188835877944,0,0,1.9923060251408755,6.70966554607822,DSP;GJA1;JUP;ITGB4;LAMA1;CACNA2D1;LEF1;CACNA2D3;ITGA6;SGCG;DSC2
39,KEGG_2021_Human,Retrograde endocannabinoid signaling,18/148,0.0375158354213799,0.2757413903471425,0,0,1.6569260915439885,5.439675363659489,GABRQ;GABRA1;GABRA5;KCNJ9;GABRA4;GABRA3;CACNA1B;NDUFA4L2;ADCY2;ADCY8;GABRG3;GABRG2;GRM1;MAPK12;GNGT1;GABRR1;SLC17A7;GABRE
40,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,13/98,0.0389743854474503,0.2794748615012292,0,0,1.828722426470588,5.933931121336684,CALML5;TRPA1;PLA2G4B;TRPV3;HTR2C;CALML3;ALOX12;ADCY2;IL1RAP;ADCY8;MAPK12;TRPV4;ASIC1
41,KEGG_2021_Human,Maturity onset diabetes of the young,5/26,0.0464690710901551,0.3252834976310862,0,0,2.842030594621268,8.722101875100511,PAX6;NKX6-1;MAFA;GCK;NEUROG3
42,KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",2/5,0.0512006628092079,0.350069648044352,0,0,7.9500107735401855,23.6274542911402,GCK;HK2
43,KEGG_2021_Human,p53 signaling pathway,10/73,0.0542127162420213,0.3622395130716878,0,0,1.896510824386068,5.5280251960998115,TP53AIP1;CCNB2;CCND2;CDK6;SESN3;PERP;SFN;SERPINB5;RPRM;TP73
44,KEGG_2021_Human,Wnt signaling pathway,19/166,0.0558806522105335,0.3650869277754861,0,0,1.546289626961896,4.460329754619793,WNT10B;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;FZD10;DKK4;WNT6;SFRP1;CCND2;VANGL2;WNT11;TBL1Y;DVL3;SOST;LGR5
45,KEGG_2021_Human,Systemic lupus erythematosus,16/135,0.0580264481961255,0.3708646906448022,0,0,1.6078321739654766,4.577267264724174,H2BC9;H3C8;H2AC8;H2BC3;MACROH2A2;H2AC11;H2AC12;H3C15;C9;H2BC11;H3C1;H4C2;H4C1;H2BW1;H2BW2;H3C7
46,KEGG_2021_Human,Fluid shear stress and atherosclerosis,16/139,0.0716565284189199,0.4466438417285563,0,0,1.5552055324858531,4.099321183039014,GSTM4;GSTM3;GSTM2;GSTM1;CALML5;IL1R2;CALML3;SELE;MAPK12;NPPC;THBD;IL1A;TRPV4;GPC1;GSTA1;GSTM5
47,KEGG_2021_Human,Phosphonate and phosphinate metabolism,2/6,0.0729214435475194,0.4466438417285563,0,0,5.96218487394958,15.6112211109126,PCYT1B;PCYT1A
48,KEGG_2021_Human,ECM-receptor interaction,11/88,0.0771235219666582,0.4627411317999494,0,0,1.7066691436002228,4.373078493652263,FRAS1;SV2B;ITGB4;LAMA1;LAMB4;COL4A6;COL9A1;COL4A5;LAMC2;ITGA6;COL9A3
49,KEGG_2021_Human,Human papillomavirus infection,33/331,0.0809439058190551,0.4759501662160443,0,0,1.3260102530502382,3.33358829762094,NOTCH3;WNT2B;ITGB4;LAMA1;PARD6G;LAMC2;FZD10;WNT6;CCND2;WNT11;HEY1;EIF4EBP1;DVL3;HRAS;HES2;WNT10B;JAG1;WNT3A;FZD7;WNT7B;FZD6;WNT5A;LAMB4;CCNA1;DLG1;CDK6;PPP2R2C;PPP2R2B;COL9A1;COL4A6;COL4A5;COL9A3;ITGA6
50,KEGG_2021_Human,Cholesterol metabolism,7/50,0.0891218958557822,0.5137615172862743,0,0,1.9433535426658224,4.698543474677481,ABCG8;ABCG5;STAR;APOA2;PCSK9;APOA1;LPA
51,KEGG_2021_Human,Rap1 signaling pathway,22/210,0.091044354826416,0.5147507753647369,0,0,1.3995805988658057,3.3539668093217148,VAV3;NGFR;CALML5;PARD6G;CALML3;LPAR3;ADCY2;ADCY8;FGF3;PGF;MAPK12;FGF4;FGF8;LPAR5;FGF19;P2RY1;FGF20;DRD2;HRAS;FGFR3;FGFR2;PFN2
52,KEGG_2021_Human,Cholinergic synapse,13/113,0.0975531342541806,0.5385761511180052,0,0,1.55314453125,3.6147234784203106,KCNJ4;CHRM3;CHRNB4;CHRNA4;CHRNA7;CHRNA6;CACNA1B;ADCY2;ADCY8;GNGT1;SLC5A7;HRAS;SLC18A3
53,KEGG_2021_Human,Cell cycle,14/124,0.0989221502053478,0.5385761511180052,0,0,1.520722534794196,3.5180731195870036,BUB1B;TTK;PKMYT1;CDC25A;CCNB2;CCNA1;CCND2;ORC6;CDK6;CDC45;SFN;MCM5;SKP2;MCM2
54,KEGG_2021_Human,Apelin signaling pathway,15/137,0.109498962044688,0.5740976482182512,0,0,1.4690779490029282,3.249365677487344,NOTCH3;JAG1;CALML5;NOS2;SPHK1;UCP1;CALML3;ADCY2;ADCY8;PRKAG3;RYR3;GNGT1;ADCY10;NOS1;HRAS
55,KEGG_2021_Human,Fat digestion and absorption,6/43,0.1122052056712832,0.5740976482182512,0,0,1.935226217792647,4.233163932991877,PLA2G2F;ABCG8;ABCG5;PLA2G3;APOA1;CEL
56,KEGG_2021_Human,Axon guidance,19/182,0.1127291566823711,0.5740976482182512,0,0,1.3932876217971852,3.041222494296311,EPHA7;EPHA6;SEMA6A;EPHA8;DCC;SEMA3D;SEMA6D;WNT5A;LRRC4;PARD6G;SEMA3F;BMP7;NTN1;RGMA;SMO;EPHB1;HRAS;PAK5;EPHB3
57,KEGG_2021_Human,PI3K-Akt signaling pathway,34/354,0.113257359172308,0.5740976482182512,0,0,1.2715635313531353,2.769583035515492,EPO;ITGB4;LAMA1;LPAR3;LAMC2;FGF3;FGF4;GNGT1;NTF4;GHR;CCND2;FGF8;MYB;NTF3;EIF4EBP1;FGF20;HRAS;NGFR;NTRK2;LAMB4;PGF;CDK6;LPAR5;PPP2R2C;PPP2R2B;FGF19;COL9A1;COL4A6;COL4A5;COL9A3;ITGA6;SGK1;FGFR3;FGFR2
58,KEGG_2021_Human,Choline metabolism in cancer,11/98,0.1363696606479583,0.6667557693542884,0,0,1.509678190813566,3.0078616731335854,SLC5A7;PCYT1B;PCYT1A;DGKA;SLC22A2;PLA2G4B;SLC22A1;EIF4EBP1;PLD1;WASF1;HRAS
59,KEGG_2021_Human,Folate biosynthesis,4/26,0.1377628640570463,0.6667557693542884,0,0,2.168755516328332,4.298953700640054,AKR1B10;AKR1C3;GGH;ALPI
60,KEGG_2021_Human,Phenylalanine metabolism,3/17,0.1399647717532077,0.6667557693542884,0,0,2.55548881907226,5.025022540918236,ALDH3A1;ALDH3B2;MIF
61,KEGG_2021_Human,mTOR signaling pathway,16/154,0.1406083595236934,0.6667557693542884,0,0,1.38502699074468,2.7171138805601487,WNT10B;WNT2B;WNT3A;FZD7;WNT7B;WNT5A;FZD6;FZD10;WNT6;SLC7A5;WNT11;EIF4EBP1;DVL3;SKP2;SGK1;HRAS
62,KEGG_2021_Human,Glycolysis / Gluconeogenesis,8/67,0.1451626085903204,0.6774255067548287,0,0,1.6183196031632552,3.1231961776114083,ALDH3A1;ALDH3B2;PGM2;ALDOC;ADH7;GAPDH;HK2;GCK
63,KEGG_2021_Human,Serotonergic synapse,12/113,0.1645645346111204,0.7466590691014735,0,0,1.4184762653233445,2.559573012007686,GNGT1;HTR7;HTR1E;KCNJ9;PLA2G4B;ALOX15;CACNA1B;HTR3C;HTR2C;ALOX12;ALOX12B;HRAS
64,KEGG_2021_Human,Alzheimer disease,34/369,0.166035214805242,0.7466590691014735,0,0,1.2136229742377225,2.1791272555172285,CHRM3;WNT2B;CALML5;CHRNA7;NDUFA4L2;IRS4;CALML3;GPR83;FZD10;RYR3;WNT6;TUBB6;KLC3;WNT11;PSMD2;DVL3;NOS1;HRAS;SNCA;WNT10B;COX8C;MME;NOS2;WNT3A;FZD7;WNT7B;FZD6;WNT5A;COX6B2;DKK4;IL1A;PPIF;GAPDH;CDK5R1
65,KEGG_2021_Human,Phototransduction,4/28,0.1676173420431879,0.7466590691014735,0,0,1.9878101402373247,3.5503712843351622,GNGT1;CALML5;GRK7;CALML3
66,KEGG_2021_Human,Ether lipid metabolism,6/49,0.1761054310115287,0.7716582706587195,0,0,1.6646520670997302,2.890955339585281,PLA2G2F;PLA2G4B;PLA2G3;PEDS1;ENPP6;PLD1
67,KEGG_2021_Human,Synthesis and degradation of ketone bodies,2/10,0.1784787836897718,0.7716582706587195,0,0,2.9804460245636717,5.136159547931212,BDH1;HMGCS1
68,KEGG_2021_Human,Linoleic acid metabolism,4/29,0.1833299743720949,0.7811451081941437,0,0,1.9081941747572817,3.2371896133530496,PLA2G2F;PLA2G4B;ALOX15;PLA2G3
69,KEGG_2021_Human,Ras signaling pathway,22/232,0.1890217562518557,0.7938913762577942,0,0,1.251448529641064,2.084779543248037,PLA2G2F;NGFR;NTRK2;CALML5;PLA2G4B;PLA2G3;CALML3;PLD1;FGF3;PGF;FGF4;GNGT1;NTF4;HTR7;FGF8;FGF19;NTF3;FGF20;HRAS;FGFR3;PAK5;FGFR2
70,KEGG_2021_Human,Ovarian steroidogenesis,6/51,0.2001268170039043,0.8286941436499702,0,0,1.59049470728019,2.558794292160085,STAR;PLA2G4B;HSD17B1;AKR1C3;ADCY2;ADCY8
71,KEGG_2021_Human,Ferroptosis,5/41,0.2087533670145142,0.8524095819759332,0,0,1.6565018710420265,2.595078789637753,GCLC;TFRC;ALOX15;SLC7A11;GCLM
72,KEGG_2021_Human,Circadian entrainment,10/97,0.2175357495462957,0.8761028817343967,0,0,1.371542948473781,2.092140745810858,GNGT1;ADCY10;CALML5;KCNJ9;PRKG2;CALML3;ADCY2;NOS1;ADCY8;RYR3
73,KEGG_2021_Human,Cortisol synthesis and secretion,7/65,0.2366565129761939,0.930782050558694,0,0,1.4395880853347645,2.0746558931251484,NR5A1;POMC;STAR;KCNA4;ADCY2;ADCY8;KCNK2
74,KEGG_2021_Human,Arginine biosynthesis,3/22,0.240363514390693,0.930782050558694,0,0,1.88248110573977,2.683670444964549,NOS2;ARG1;NOS1
75,KEGG_2021_Human,Gap junction,9/88,0.2406103259947644,0.930782050558694,0,0,1.359099128719382,1.9361407596940328,GJA1;TUBB6;HTR2C;PRKG2;ADCY2;ADCY8;DRD2;HRAS;GRM1
76,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,10/100,0.245640637709112,0.9379006167075188,0,0,1.3256082593314562,1.8610023908072637,CXCL6;IL20;IL24;IL20RB;IL19;XCL1;ACKR3;CXCL1;CXCL13;CCL26
77,KEGG_2021_Human,Regulation of lipolysis in adipocytes,6/55,0.2513523873588175,0.947405152352466,0,0,1.4603409737193649,2.0165839608866567,FABP4;NPY;IRS4;PRKG2;ADCY2;ADCY8
78,KEGG_2021_Human,Synaptic vesicle cycle,8/78,0.2558658359739167,0.9522095667890068,0,0,1.3631964401594512,1.8581758622791704,CLTCL1;CACNA1B;SLC6A11;SLC17A7;SLC1A6;SLC6A2;AP2M1;SLC18A3
79,KEGG_2021_Human,Pancreatic secretion,10/102,0.2650513313516199,0.9604982526411612,0,0,1.2966494335678165,1.721732310551132,PLA2G2F;CHRM3;CPA2;CLCA2;PLA2G3;ATP1B3;ADCY2;CEL;ADCY8;CLCA4
80,KEGG_2021_Human,ABC transporters,5/45,0.2675380998157359,0.9604982526411612,0,0,1.4905278497409329,1.9652509737634023,ABCG8;ABCC1;ABCG5;ABCC5;ABCA13
81,KEGG_2021_Human,Leukocyte transendothelial migration,11/114,0.2678940704645415,0.9604982526411612,0,0,1.2740540608784576,1.6781376793733058,VAV3;CLDN11;CLDN20;MYL7;CLDN8;CLDN24;CLDN19;CLDN17;CLDN16;CLDN1;MAPK12
82,KEGG_2021_Human,Small cell lung cancer,9/92,0.2822538046480881,0.9631247465188356,0,0,1.2933187294633075,1.6359817114463415,CDK6;NOS2;LAMA1;LAMB4;COL4A6;COL4A5;LAMC2;ITGA6;SKP2
83,KEGG_2021_Human,Type II diabetes mellitus,5/46,0.2827868668118186,0.9631247465188356,0,0,1.454094527991912,1.8366112313683611,CACNA1B;IRS4;MAFA;HK2;GCK
84,KEGG_2021_Human,Vitamin digestion and absorption,3/24,0.2834116064519654,0.9631247465188356,0,0,1.7030123821844392,2.147251674162904,ABCC1;FOLH1;APOA1
85,KEGG_2021_Human,Neutrophil extracellular trap formation,17/189,0.2956545790716895,0.9631247465188356,0,0,1.1792724209120165,1.4370182917508187,H2BC9;H3C8;H2AC8;H2BC3;MACROH2A2;MAPK12;H2AC11;H2AC12;H3C15;H2BC11;PPIF;H3C1;H4C2;H4C1;H2BW1;H2BW2;H3C7
86,KEGG_2021_Human,Central carbon metabolism in cancer,7/70,0.297688790513833,0.9631247465188356,0,0,1.3249747802276983,1.6054807725577032,SLC7A5;SLC2A1;HRAS;FGFR3;HK2;GCK;FGFR2
87,KEGG_2021_Human,Carbohydrate digestion and absorption,5/47,0.2981956060068418,0.9631247465188356,0,0,1.419396126326178,1.7174772782420786,MGAM2;GNAT3;TAS1R2;ATP1B3;HK2
88,KEGG_2021_Human,DNA replication,4/36,0.3033106261013198,0.9631247465188356,0,0,1.490210355987055,1.7778177208586892,RNASEH2A;RFC4;MCM5;MCM2
89,KEGG_2021_Human,Starch and sucrose metabolism,4/36,0.3033106261013198,0.9631247465188356,0,0,1.490210355987055,1.7778177208586892,MGAM2;PGM2;HK2;GCK
90,KEGG_2021_Human,Tyrosine metabolism,4/36,0.3033106261013198,0.9631247465188356,0,0,1.490210355987055,1.7778177208586892,ALDH3B2;ALDH3A1;MIF;ADH7
91,KEGG_2021_Human,alpha-Linolenic acid metabolism,3/25,0.3051880517306382,0.9631247465188356,0,0,1.6255145242855462,1.9292047365263616,PLA2G2F;PLA2G4B;PLA2G3
92,KEGG_2021_Human,Pathways of neurodegeneration,40/475,0.3124044509824907,0.9631247465188356,0,0,1.0978420663756925,1.277291612609844,CHRM3;WNT2B;CALML5;CHRNA7;NDUFA4L2;CACNA1B;CALML3;FZD10;RYR3;GRM1;WNT6;TUBB6;KLC3;UCHL1;WNT11;PSMD2;NEFL;DVL3;NEFM;NOS1;HRAS;SNCA;WNT10B;GPX2;COX8C;DNAH17;NOS2;WNT3A;FZD7;WNT7B;FZD6;WNT5A;SEPTIN5;COX6B2;MAPK12;DKK4;IL1A;PPIF;HAP1;CDK5R1
93,KEGG_2021_Human,Transcriptional misregulation in cancer,17/192,0.3184399893962833,0.9631247465188356,0,0,1.1588660947407683,1.3261150842803326,NGFR;H3C8;BCL11B;JUP;IL1R2;DEFA5;MMP3;PAX3;HOXA11;HOXA10;CCNA1;H3C15;CCND2;TLX3;TLX1;H3C1;H3C7
94,KEGG_2021_Human,Long-term depression,6/60,0.3196321245750201,0.9631247465188356,0,0,1.324764167926838,1.5110055492206471,PPP1R17;PLA2G4B;PRKG2;NOS1;HRAS;GRM1
95,KEGG_2021_Human,Mineral absorption,6/60,0.3196321245750201,0.9631247465188356,0,0,1.324764167926838,1.5110055492206471,SLC9A3;HEPHL1;TRPV6;MT1X;ATP1B3;CLCN2
96,KEGG_2021_Human,Cellular senescence,14/156,0.3226703017659793,0.9631247465188356,0,0,1.1759691700692756,1.3301672039277872,CALML5;CALML3;GATA4;FOXM1;CDC25A;MAPK12;CCNB2;CCNA1;IL1A;CCND2;CDK6;TRPV4;EIF4EBP1;HRAS
97,KEGG_2021_Human,Melanoma,7/72,0.3230108810778014,0.9631247465188356,0,0,1.2840666467125612,1.4510842565146345,FGF8;CDK6;FGF19;FGF20;HRAS;FGF3;FGF4
98,KEGG_2021_Human,Proteoglycans in cancer,18/205,0.324317516684914,0.9631247465188356,0,0,1.148290062417699,1.2930116464239454,VAV3;WNT10B;WNT2B;WNT3A;FZD7;WNT7B;FZD6;WNT5A;TWIST1;FZD10;HOXD10;MAPK12;WNT6;WNT11;SMO;GPC1;GPC3;HRAS
99,KEGG_2021_Human,Vascular smooth muscle contraction,12/133,0.3341689118170713,0.9767880762150752,0,0,1.1827268963366435,1.296397228779149,PLA2G2F;NPPC;CALML5;EDN3;PLA2G4B;KCNMB2;PLA2G3;CALML3;ADM;ADRA1D;ADCY2;ADCY8
100,KEGG_2021_Human,Primary immunodeficiency,4/38,0.339343841765431,0.9767880762150752,0,0,1.4023986293546544,1.5156302624569844,AIRE;CD8B2;ADA;RAG1
101,KEGG_2021_Human,Arginine and proline metabolism,5/50,0.3450860179423957,0.9767880762150752,0,0,1.3245538284398388,1.409274365105702,NOS2;ARG1;CKMT1A;CKMT1B;NOS1
102,KEGG_2021_Human,Glycerophospholipid metabolism,9/98,0.3478611378377337,0.9767880762150752,0,0,1.2057347147234787,1.273197872605836,PLA2G2F;PTDSS1;PCYT1B;PCYT1A;ETNK2;DGKA;PLA2G4B;PLA2G3;PLD1
103,KEGG_2021_Human,Insulin secretion,8/86,0.3485858376153142,0.9767880762150752,0,0,1.2228489658729762,1.2887247851513033,RIMS2;CHRM3;KCNMB2;SLC2A1;ATP1B3;ADCY2;ADCY8;GCK
104,KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,3/27,0.3488528843625268,0.9767880762150752,0,0,1.489893272962484,1.5690140260634569,ELOVL4;ELOVL2;SCD5
105,KEGG_2021_Human,Hematopoietic cell lineage,9/99,0.3590342562294556,0.9958119936930184,0,0,1.1922727272727274,1.2212896335282797,IL11;IL1A;TFRC;MME;EPO;IL1R2;CD8B2;DNTT;ITGA6
106,KEGG_2021_Human,Butanoate metabolism,3/28,0.370601144460877,0.9999949078281076,0,0,1.4302199223803365,1.419677595423885,HMGCS1;BDH1;GAD2
107,KEGG_2021_Human,Vitamin B6 metabolism,1/6,0.3835292093403519,0.9999949078281076,0,0,2.3832041343669252,2.2839186487830556,PSAT1
108,KEGG_2021_Human,Nitrogen metabolism,2/17,0.3835390826486282,0.9999949078281076,0,0,1.5889678948502477,1.5227297866161773,CA12;CA9
109,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,5/53,0.3923824996087382,0.9999949078281076,0,0,1.2415668177892918,1.161508293264553,CALB1;CLTCL1;ATP1B3;KLK2;AP2M1
110,KEGG_2021_Human,Glycosaminoglycan biosynthesis,5/53,0.3923824996087382,0.9999949078281076,0,0,1.2415668177892918,1.161508293264553,CHST7;HS3ST3A1;HS6ST1;B4GALT4;CHST2
111,KEGG_2021_Human,cAMP signaling pathway,18/216,0.4086069485512151,0.9999949078281076,0,0,1.0838430021970191,0.9700412113485088,VAV3;GHSR;CALML5;EDN3;HTR1E;CALML3;ADCY2;ATP1B3;GLI1;ADCY8;PLD1;SSTR2;HCAR2;POMC;HCAR3;ADCY10;NPY;DRD2
112,KEGG_2021_Human,Pentose phosphate pathway,3/30,0.4136215180407065,0.9999949078281076,0,0,1.324133965789852,1.1689506700780434,TKTL1;PGM2;ALDOC
113,KEGG_2021_Human,beta-Alanine metabolism,3/30,0.4136215180407065,0.9999949078281076,0,0,1.324133965789852,1.1689506700780434,ALDH3B2;ALDH3A1;GAD2
114,KEGG_2021_Human,Relaxin signaling pathway,11/129,0.4156882140428699,0.9999949078281076,0,0,1.1111888651341164,0.9754235709079914,GNGT1;MMP13;NOS2;MMP1;COL4A6;COL4A5;ADCY2;NOS1;ADCY8;HRAS;MAPK12
115,KEGG_2021_Human,Regulation of actin cytoskeleton,18/218,0.4241987151160233,0.9999949078281076,0,0,1.0728870019595036,0.9200577523798988,VAV3;CHRM3;ITGB4;FGF3;FGF4;MYL7;FGF8;LPAR5;FGF19;FGF20;ARHGEF4;ITGA6;WASF1;HRAS;FGFR3;PAK5;FGFR2;PFN2
116,KEGG_2021_Human,GnRH signaling pathway,8/93,0.4326869307961752,0.9999949078281076,0,0,1.1217162270488987,0.9397074898617784,CALML5;PLA2G4B;CALML3;ADCY2;ADCY8;PLD1;HRAS;MAPK12
117,KEGG_2021_Human,Tight junction,14/169,0.4370913197588677,0.9999949078281076,0,0,1.0765745508038247,0.8909872401476508,PARD6G;GATA4;CLDN1;PRKAG3;CLDN11;DLG1;CLDN20;PPP2R2C;PPP2R2B;CLDN8;CLDN24;CLDN19;CLDN17;CLDN16
118,KEGG_2021_Human,Hedgehog signaling pathway,5/56,0.4393888606558453,0.9999949078281076,0,0,1.1683429848623388,0.9608107702999682,CCND2;SMO;GLI1;KIF7;GLI2
119,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",10/119,0.4422547343343863,0.9999949078281076,0,0,1.0934062986211706,0.8920765668411617,GHR;GHSR;ADCY10;GHRH;IRS4;ADCY2;SSTR2;ADCY8;HRAS;MAPK12
120,KEGG_2021_Human,Sphingolipid signaling pathway,10/119,0.4422547343343863,0.9999949078281076,0,0,1.0934062986211706,0.8920765668411617,CERS3;ACER1;ABCC1;PPP2R2C;PPP2R2B;SPHK1;PLD1;S1PR5;HRAS;MAPK12
121,KEGG_2021_Human,Renin secretion,6/69,0.4466264995213058,0.9999949078281076,0,0,1.1349566398173008,0.9148120571738864,CALML5;EDN3;CLCA2;PRKG2;CALML3;CLCA4
122,KEGG_2021_Human,Glycosphingolipid biosynthesis,4/45,0.4644891285939777,0.9999949078281076,0,0,1.162522693188097,0.89144230996097,B3GNT5;B4GALNT1;A4GALT;B4GALT4
123,KEGG_2021_Human,Steroid biosynthesis,2/20,0.4657896025204724,0.9999949078281076,0,0,1.3239244415715004,1.0115063982143944,CEL;DHCR7
124,KEGG_2021_Human,Dilated cardiomyopathy,8/96,0.4685354519122854,0.9999949078281076,0,0,1.0832989204176744,0.8212960448890113,ITGB4;LAMA1;CACNA2D1;CACNA2D3;ITGA6;ADCY2;ADCY8;SGCG
125,KEGG_2021_Human,Fructose and mannose metabolism,3/33,0.4762020002227964,0.9999949078281076,0,0,1.1915265200517464,0.8840091873114707,AKR1B10;ALDOC;HK2
126,KEGG_2021_Human,Notch signaling pathway,5/59,0.4854971818645193,0.9999949078281076,0,0,1.1032551333717138,0.7971920755768417,JAG2;NOTCH3;JAG1;HEY1;DVL3
127,KEGG_2021_Human,VEGF signaling pathway,5/59,0.4854971818645193,0.9999949078281076,0,0,1.1032551333717138,0.7971920755768417,PLA2G4B;SPHK1;HSPB1;HRAS;MAPK12
128,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,4/48,0.5157037914710387,0.9999949078281076,0,0,1.0830832597822888,0.7172423486325253,CYB5R2;PGM2;HK2;GCK
129,KEGG_2021_Human,Histidine metabolism,2/22,0.5168770789301032,0.9999949078281076,0,0,1.191402714932127,0.7862664493946174,ALDH3A1;ALDH3B2
130,KEGG_2021_Human,Sphingolipid metabolism,4/49,0.5322664218953135,0.9999949078281076,0,0,1.0589572096368214,0.6677901940758303,CERS3;NEU2;ACER1;SPHK1
131,KEGG_2021_Human,cGMP-PKG signaling pathway,13/167,0.5342307726137064,0.9999949078281076,0,0,1.0055676745129871,0.6304179024897297,CALML5;IRS4;CALML3;ATP1B3;GATA4;ADRA1D;ADCY2;ADCY8;ADRA2B;NPPC;KCNMB2;PPIF;PRKG2
132,KEGG_2021_Human,Oxytocin signaling pathway,12/154,0.5347767342566708,0.9999949078281076,0,0,1.006661962667351,0.630075700328866,KCNJ4;CALML5;KCNJ9;CACNA2D1;PLA2G4B;CACNA2D3;CALML3;ADCY2;ADCY8;HRAS;PRKAG3;RYR3
133,KEGG_2021_Human,Longevity regulating pathway,8/102,0.5384353311498663,0.9999949078281076,0,0,1.013820812680354,0.6276441779388329,SESN3;IRS4;EIF4EBP1;ADCY2;ADCY8;HRAS;CRYAB;PRKAG3
134,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,2/23,0.5411724650953762,0.9999949078281076,0,0,1.134607689229538,0.6966687061980584,SLC9A3;ATP1B3
135,KEGG_2021_Human,Renin-angiotensin system,2/23,0.5411724650953762,0.9999949078281076,0,0,1.134607689229538,0.6966687061980584,MME;KLK2
136,KEGG_2021_Human,Pertussis,6/76,0.5419975713607657,0.9999949078281076,0,0,1.0210721229515785,0.6254003022215794,CXCL6;IL1A;CALML5;NOS2;CALML3;MAPK12
137,KEGG_2021_Human,Cysteine and methionine metabolism,4/50,0.5485429696439792,0.9999949078281076,0,0,1.0358801181933306,0.6220353021029548,GCLC;PSAT1;PHGDH;GCLM
138,KEGG_2021_Human,Hypertrophic cardiomyopathy,7/90,0.5520773180076232,0.9999949078281076,0,0,1.004609879205538,0.5968057515699231,ITGB4;LAMA1;CACNA2D1;CACNA2D3;ITGA6;PRKAG3;SGCG
139,KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,3/37,0.5543998522367423,0.9999949078281076,0,0,1.0511186363290466,0.6200224015184539,SFN;ATP1B3;SGK1
140,KEGG_2021_Human,Hepatitis C,12/157,0.5623403038723281,0.9999949078281076,0,0,0.9856729410181052,0.5674007453087612,CLDN11;CLDN20;CDK6;PPP2R2C;PPP2R2B;CLDN8;CLDN24;CLDN19;CLDN17;CLDN16;CLDN1;HRAS
141,KEGG_2021_Human,FoxO signaling pathway,10/131,0.566367119087755,0.9999949078281076,0,0,0.9843249077698838,0.5596013003168546,CCNB2;CCND2;IRS4;SKP2;SGK1;HRAS;GRM1;PRKAG3;MAPK12;RAG1
142,KEGG_2021_Human,Neurotrophin signaling pathway,9/119,0.5793034474516784,0.9999949078281076,0,0,0.9744332939787486,0.531971247420549,NTF4;NGFR;NTRK2;CALML5;NTF3;CALML3;HRAS;MAPK12;TP73
143,KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.5881021646459581,0.9999949078281076,0,0,1.1912790697674418,0.6323959702318244,GAD2
144,KEGG_2021_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.5881021646459581,0.9999949078281076,0,0,1.1912790697674418,0.6323959702318244,COQ3
145,KEGG_2021_Human,Glucagon signaling pathway,8/107,0.5938038620666214,0.9999949078281076,0,0,0.9623555476897464,0.5015856902707312,CALML5;GCGR;PPP4R3C;SLC2A1;CALML3;ADCY2;PRKAG3;GCK
146,KEGG_2021_Human,Focal adhesion,15/201,0.5981899854573168,0.9999949078281076,0,0,0.9602241662110444,0.4934081861989217,VAV3;ITGB4;LAMA1;LAMB4;LAMC2;PGF;MYL7;CCND2;COL9A1;COL4A6;COL4A5;COL9A3;ITGA6;HRAS;PAK5
147,KEGG_2021_Human,MAPK signaling pathway,22/294,0.5991055659492583,0.9999949078281076,0,0,0.9629078546939404,0.4933145057699937,NGFR;NTRK2;CACNA2D1;PLA2G4B;CACNA2D3;CACNA1B;HSPB1;IL1RAP;DUSP9;FGF3;PGF;MAPK12;FGF4;NTF4;IL1A;FGF8;FGF19;NTF3;FGF20;HRAS;FGFR3;FGFR2
148,KEGG_2021_Human,Acute myeloid leukemia,5/67,0.6004832278485333,0.9999949078281076,0,0,0.9604817817148588,0.489865464020112,CCNA1;JUP;LEF1;EIF4EBP1;HRAS
149,KEGG_2021_Human,Long-term potentiation,5/67,0.6004832278485333,0.9999949078281076,0,0,0.9604817817148588,0.489865464020112,CALML5;CALML3;ADCY8;HRAS;GRM1
150,KEGG_2021_Human,JAK-STAT signaling pathway,12/162,0.6067830037620525,0.9999949078281076,0,0,0.9525569290826283,0.4758822404098488,GHR;CNTFR;IL11;CCND2;IL20;TSLP;EPO;IL24;IL20RB;IL19;HRAS;IL12RB2
151,KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,2/26,0.6088413364952678,0.9999949078281076,0,0,0.9926201249730662,0.4925357003201793,PGAP1;PIGX
152,KEGG_2021_Human,Fanconi anemia pathway,4/54,0.6104971597294473,0.9999949078281076,0,0,0.9528025889967636,0.4701905821277481,FANCI;RAD51;FANCB;FANCE
153,KEGG_2021_Human,HIF-1 signaling pathway,8/109,0.6150163867711972,0.9999949078281076,0,0,0.9431962015150248,0.4584936782963946,TFRC;NOS2;EPO;EIF4EBP1;SLC2A1;ALDOC;GAPDH;HK2
154,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,11/150,0.619406134808089,0.9999949078281076,0,0,0.942230870700059,0.4513230345509955,CALML5;PPP2R2C;PPP2R2B;CACNA2D1;CACNA2D3;CALML3;ATP1B3;ADRA1D;ADCY2;ADCY8;MAPK12
155,KEGG_2021_Human,Bladder cancer,3/41,0.6251900127410074,0.9999949078281076,0,0,0.9402703070742834,0.4416446389006117,MMP1;HRAS;FGFR3
156,KEGG_2021_Human,Adipocytokine signaling pathway,5/69,0.6268692469753055,0.9999949078281076,0,0,0.9303655278497408,0.4344967946111318,POMC;NPY;IRS4;SLC2A1;PRKAG3
157,KEGG_2021_Human,Collecting duct acid secretion,2/27,0.6296403958706562,0.9999949078281076,0,0,0.952863606981254,0.4408008246136233,ATP4B;ATP4A
158,KEGG_2021_Human,Fatty acid elongation,2/27,0.6296403958706562,0.9999949078281076,0,0,0.952863606981254,0.4408008246136233,ELOVL4;ELOVL2
159,KEGG_2021_Human,Prolactin signaling pathway,5/70,0.639659994487378,0.9999949078281076,0,0,0.9160023913909924,0.4092868167250716,CCND2;CSN2;HRAS;GCK;MAPK12
160,KEGG_2021_Human,Aldosterone synthesis and secretion,7/98,0.6432148983647377,0.9999949078281076,0,0,0.9158934450763244,0.4041621608577417,POMC;CALML5;STAR;CALML3;ATP1B3;ADCY2;ADCY8
161,KEGG_2021_Human,Non-homologous end-joining,1/13,0.6494680506632747,0.9999949078281076,0,0,0.9926248923341948,0.4284185262210973,DNTT
162,KEGG_2021_Human,Complement and coagulation cascades,6/85,0.6525523000224639,0.9999949078281076,0,0,0.9043044537601418,0.3860150070411938,THBD;SERPINB2;C9;CFHR4;F2RL2;MBL2
163,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,7/100,0.664229741899619,0.9999949078281076,0,0,0.8960991869238386,0.3666185445584626,THBD;IL1A;COL4A6;COL4A5;SELE;HRAS;MAPK12
164,KEGG_2021_Human,Progesterone-mediated oocyte maturation,7/100,0.664229741899619,0.9999949078281076,0,0,0.8960991869238386,0.3666185445584626,CCNB2;CCNA1;ADCY2;PKMYT1;ADCY8;CDC25A;MAPK12
165,KEGG_2021_Human,Glutamatergic synapse,8/114,0.665368078865207,0.9999949078281076,0,0,0.8984609356825389,0.3660463627405138,GNGT1;PLA2G4B;ADCY2;SLC17A7;PLD1;SLC1A6;ADCY8;GRM1
166,KEGG_2021_Human,Pathogenic Escherichia coli infection,14/197,0.6704600861985369,0.9999949078281076,0,0,0.9104572720314698,0.363992720157364,WIPF3;CLDN1;MAPK12;CLDN11;CLDN20;TUBB6;LPAR5;CLDN8;CLDN24;CLDN19;CLDN17;CLDN16;WASF1;GAPDH
167,KEGG_2021_Human,Cardiac muscle contraction,6/87,0.674762148024521,0.9999949078281076,0,0,0.8818799356712513,0.3469271780216902,COX8C;CACNA2D1;CACNA2D3;ATP1B3;COX6B2;TRDN
168,KEGG_2021_Human,Thyroid hormone synthesis,5/75,0.6993989177012657,0.9999949078281076,0,0,0.8503423390081422,0.3040262993838429,GPX2;TG;ATP1B3;ADCY2;ADCY8
169,KEGG_2021_Human,Thiamine metabolism,1/15,0.7016964237113816,0.9999949078281076,0,0,0.8507290513104466,0.3013745209859568,ALPI
170,KEGG_2021_Human,Dopaminergic synapse,9/132,0.7022201406037534,0.9999949078281076,0,0,0.8708267342413684,0.3078445075993155,GNGT1;CALML5;PPP2R2C;KCNJ9;PPP2R2B;CACNA1B;CALML3;DRD2;MAPK12
171,KEGG_2021_Human,Glycerolipid metabolism,4/61,0.7053914694025861,0.9999949078281076,0,0,0.835473797763016,0.2915823225674569,AKR1B10;DGKA;CEL;PNLIPRP3
172,KEGG_2021_Human,Other types of O-glycan biosynthesis,3/47,0.7160946051504108,0.9999949078281076,0,0,0.8117870163471715,0.2710905840110853,COLGALT2;XXYLT1;GALNT8
173,KEGG_2021_Human,Phospholipase D signaling pathway,10/148,0.718279201197159,0.9999949078281076,0,0,0.8622670471132206,0.2853215152068311,LPAR5;DGKA;PLA2G4B;SPHK1;LPAR3;ADCY2;PLD1;ADCY8;HRAS;GRM1
174,KEGG_2021_Human,Rheumatoid arthritis,6/93,0.7357345861355337,0.9999949078281076,0,0,0.8207924553601359,0.2518895837333127,CXCL6;IL11;IL1A;MMP1;MMP3;CXCL1
175,KEGG_2021_Human,Other glycan degradation,1/18,0.765824650691368,0.9999949078281076,0,0,0.7004863961088311,0.1868912071746893,NEU2
176,KEGG_2021_Human,Toxoplasmosis,7/112,0.7735586241763924,0.9999949078281076,0,0,0.7931690445309122,0.2036491829223412,NOS2;LAMA1;LAMB4;PPIF;LAMC2;ITGA6;MAPK12
177,KEGG_2021_Human,Mucin type O-glycan biosynthesis,2/36,0.7794123470639048,0.9999949078281076,0,0,0.7002927867979771,0.1745234979884249,ST6GALNAC2;GALNT8
178,KEGG_2021_Human,Fc epsilon RI signaling pathway,4/68,0.7823086343952504,0.9999949078281076,0,0,0.7438106796116505,0.182609942430596,VAV3;PLA2G4B;HRAS;MAPK12
179,KEGG_2021_Human,African trypanosomiasis,2/37,0.7922701836927916,0.9999949078281076,0,0,0.6802474836088281,0.1583975341877816,APOA1;SELE
180,KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",2/37,0.7922701836927916,0.9999949078281076,0,0,0.6802474836088281,0.1583975341877816,FOLH1;GAD2
181,KEGG_2021_Human,Thyroid cancer,2/37,0.7922701836927916,0.9999949078281076,0,0,0.6802474836088281,0.1583975341877816,LEF1;HRAS
182,KEGG_2021_Human,ErbB signaling pathway,5/85,0.7972733191764297,0.9999949078281076,0,0,0.7436447538860104,0.1684784629079153,NRG4;EIF4EBP1;NRG1;HRAS;PAK5
183,KEGG_2021_Human,Viral carcinogenesis,13/203,0.7997982334986855,0.9999949078281076,0,0,0.8134354440789474,0.1817180546613574,H2BC9;H2BC3;CCNA1;DLG1;CCND2;CDK6;H2BC11;H4C2;H4C1;SKP2;H2BW1;HRAS;H2BW2
184,KEGG_2021_Human,One carbon pool by folate,1/20,0.8007244720548069,0.9999949078281076,0,0,0.6266829865361077,0.1392730060893996,ALDH1L1
185,KEGG_2021_Human,Adherens junction,4/71,0.809990191989789,0.9999949078281076,0,0,0.7103897985799159,0.1497026729096467,LEF1;SNAI2;WASF1;NECTIN1
186,KEGG_2021_Human,Various types of N-glycan biosynthesis,2/39,0.8160112143631533,0.9999949078281076,0,0,0.6434074669368787,0.1308222264997298,ALG3;B4GALNT4
187,KEGG_2021_Human,T cell receptor signaling pathway,6/104,0.8253821998570918,0.9999949078281076,0,0,0.7282262224397212,0.1397529675866004,VAV3;DLG1;CD8B2;HRAS;PAK5;MAPK12
188,KEGG_2021_Human,"Glycine, serine and threonine metabolism",2/40,0.8269465681482192,0.9999949078281076,0,0,0.626441669785323,0.1190334362271692,PSAT1;PHGDH
189,KEGG_2021_Human,AMPK signaling pathway,7/120,0.830337002795687,0.9999949078281076,0,0,0.7366940991471828,0.1369688434215698,CCNA1;PPP2R2C;PPP2R2B;SCD5;IRS4;EIF4EBP1;PRKAG3
190,KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.8304258825728661,0.9999949078281076,0,0,0.5669373692629507,0.1053463733798698,HMGCS1
191,KEGG_2021_Human,Homologous recombination,2/41,0.8372930374540013,0.9999949078281076,0,0,0.6103459135133343,0.108385938545504,RAD51;RAD54L
192,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,0.8387500819869855,0.9999949078281076,0,0,0.7135839274141283,0.1254783767235799,MMP13;ADCY2;SOST;PLD1;ADCY8;PTHLH
193,KEGG_2021_Human,Insulin signaling pathway,8/137,0.8414126827603232,0.9999949078281076,0,0,0.7373446216842984,0.1273195333261041,CALML5;IRS4;EIF4EBP1;CALML3;HRAS;HK2;PRKAG3;GCK
194,KEGG_2021_Human,Glioma,4/75,0.842350770988294,0.9999949078281076,0,0,0.6702219791239346,0.1149824509043877,CDK6;CALML5;CALML3;HRAS
195,KEGG_2021_Human,Mismatch repair,1/23,0.8435737359881127,0.9999949078281076,0,0,0.541138125440451,0.0920519048235528,RFC4
196,KEGG_2021_Human,Th1 and Th2 cell differentiation,5/92,0.8494892713436312,0.9999949078281076,0,0,0.6835507116907867,0.1115007697577701,JAG2;NOTCH3;JAG1;MAPK12;IL12RB2
197,KEGG_2021_Human,Type I diabetes mellitus,2/43,0.8563211100510255,0.9999949078281076,0,0,0.580509877496965,0.0900427968984891,IL1A;GAD2
198,KEGG_2021_Human,TNF signaling pathway,6/112,0.8739451406172805,0.9999949078281076,0,0,0.6729722789469179,0.0906747191744747,CXCL6;JAG1;MMP3;CXCL1;SELE;MAPK12
199,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,5/97,0.8795280767844272,0.9999949078281076,0,0,0.646225219644064,0.0829557968620859,VAV3;PLA2G4B;SPHK1;PLD1;WASF1
200,KEGG_2021_Human,Prostate cancer,5/97,0.8795280767844272,0.9999949078281076,0,0,0.646225219644064,0.0829557968620859,IL1R2;MMP3;LEF1;HRAS;FGFR2
201,KEGG_2021_Human,Oocyte meiosis,7/129,0.8800889739578601,0.9999949078281076,0,0,0.6820129276434692,0.0871150593153085,CCNB2;CALML5;CALML3;ADCY2;PKMYT1;ADCY8;MAPK12
202,KEGG_2021_Human,Purine metabolism,7/129,0.8800889739578601,0.9999949078281076,0,0,0.6820129276434692,0.0871150593153085,ADCY10;GDA;GMPS;PGM2;ADCY2;ADCY8;ADA
203,KEGG_2021_Human,Chemokine signaling pathway,11/192,0.8860469496880143,0.9999949078281076,0,0,0.7219320492280281,0.0873431938281193,GNGT1;VAV3;CXCL6;GRK7;XCL1;CXCL1;ADCY2;CXCL13;ADCY8;HRAS;CCL26
204,KEGG_2021_Human,Pyruvate metabolism,2/47,0.8884021365233278,0.9999949078281076,0,0,0.5287940817352582,0.0625726172368957,ME1;ADH7
205,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,7/131,0.88932045251256,0.9999949078281076,0,0,0.6709395004393122,0.0786996229372164,VAV3;RAET1G;RAET1L;ULBP2;ULBP1;HRAS;ULBP3
206,KEGG_2021_Human,Cocaine addiction,2/49,0.9018234753644028,0.9999949078281076,0,0,0.5062371920945138,0.0523127703160268,DRD2;CDK5R1
207,KEGG_2021_Human,Colorectal cancer,4/86,0.9082764591420214,0.9999949078281076,0,0,0.5799668482121715,0.0557965668383699,DCC;LEF1;BIRC5;HRAS
208,KEGG_2021_Human,Renal cell carcinoma,3/69,0.9108038233640696,0.9999949078281076,0,0,0.5405445137010467,0.0505018560643896,SLC2A1;HRAS;PAK5
209,KEGG_2021_Human,Thyroid hormone signaling pathway,6/121,0.9145217712216672,0.9999949078281076,0,0,0.6200005635549043,0.0553995332950515,NOTCH3;SLC2A1;ATP1B3;GATA4;HRAS;MED12L
210,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.9157159537767386,0.9999949078281076,0,0,0.5324477225772818,0.0468815196230558,PTPRZ1;CXCL1;MAPK12
211,KEGG_2021_Human,Thermogenesis,13/232,0.9171236262692112,0.9999949078281076,0,0,0.704599505327245,0.060957016874429,COX8C;ACTL6A;NDUFA4L2;UCP1;ADCY2;ADCY8;COX6B2;PRKAG3;MAPK12;ADCY10;DPF1;PRKG2;HRAS
212,KEGG_2021_Human,Olfactory transduction,27/440,0.9179296452861816,0.9999949078281076,0,0,0.7747961297260836,0.0663493027406214,OR9K2;CALML5;OR11H4;OR1G1;CALML3;OR52L1;OR5M11;OR51Q1;OR11H6;PRKG2;OR11H7;OR56B4;OR8D1;OR6C70;OR10S1;OR56A5;OR2V2;OR2L13;OR9A4;OR7A5;OR52A1;OR13A1;OR10A3;OR6C2;OR7C1;OR10A6;OR56A1
213,KEGG_2021_Human,Circadian rhythm,1/31,0.9179938458774932,0.9999949078281076,0,0,0.396662360034453,0.0339402530858748,PRKAG3
214,KEGG_2021_Human,Parkinson disease,14/249,0.9217300595676444,0.9999949078281076,0,0,0.7069762284288585,0.0576205954102399,COX8C;CALML5;NDUFA4L2;SEPTIN5;CALML3;COX6B2;RYR3;UCHL1;TUBB6;KLC3;PSMD2;PPIF;DRD2;SNCA
215,KEGG_2021_Human,Platelet activation,6/124,0.9252566294414696,0.9999949078281076,0,0,0.6041389764601206,0.046932018466589,PLA2G4B;P2RY1;PRKG2;ADCY2;ADCY8;MAPK12
216,KEGG_2021_Human,Apoptosis,7/142,0.9300252385811312,0.9999949078281076,0,0,0.6159004659653168,0.0446796092926611,TP53AIP1;HRK;NGFR;BIRC5;CTSV;HRAS;LMNB2
217,KEGG_2021_Human,TGF-beta signaling pathway,4/94,0.9395153749078688,0.9999949078281076,0,0,0.5281841064365336,0.0329539849062464,ACVR1C;FST;BMP7;RGMA
218,KEGG_2021_Human,Pancreatic cancer,3/76,0.9403474584523284,0.9999949078281076,0,0,0.4885254036045295,0.0300471630459505,CDK6;RAD51;PLD1
219,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,1/35,0.940629232784116,0.9999949078281076,0,0,0.3499202006383949,0.021417296661652,NMNAT3
220,KEGG_2021_Human,Leishmaniasis,3/77,0.9437380572783916,0.9999949078281076,0,0,0.4818974861018845,0.0279050608898411,IL1A;NOS2;MAPK12
221,KEGG_2021_Human,Endometrial cancer,2/58,0.9455362721310152,0.9999949078281076,0,0,0.4246698679471788,0.0237827988068645,LEF1;HRAS
222,KEGG_2021_Human,Phosphatidylinositol signaling system,4/97,0.94848049802399,0.9999949078281076,0,0,0.5110623934300728,0.0270321601380995,IPPK;CALML5;DGKA;CALML3
223,KEGG_2021_Human,mRNA surveillance pathway,4/98,0.951186862968988,0.9999949078281076,0,0,0.505598016938649,0.0253025236831475,PPP2R2C;PPP2R2B;MSI1;CPSF4L
224,KEGG_2021_Human,Viral myocarditis,2/60,0.9523380758311368,0.9999949078281076,0,0,0.4099814992309921,0.0200215225911886,LAMA1;SGCG
225,KEGG_2021_Human,Chagas disease,4/102,0.9607545122143026,0.9999949078281076,0,0,0.484855689848755,0.0194118535500133,NOS2;PPP2R2C;PPP2R2B;MAPK12
226,KEGG_2021_Human,GnRH secretion,2/64,0.9635842298354914,0.9999949078281076,0,0,0.3834476718727193,0.0142241348964695,KCNJ9;HRAS
227,KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.9648573681412184,0.9999949078281076,0,0,0.4751067961165048,0.0169969425915241,CALML5;CALML3;HRAS;MAPK12
228,KEGG_2021_Human,Inflammatory bowel disease,2/65,0.9659692737630574,0.9999949078281076,0,0,0.3773406798616883,0.0130647618163051,IL1A;IL12RB2
229,KEGG_2021_Human,Graft-versus-host disease,1/42,0.9662690979939322,0.9999949078281076,0,0,0.2900674355580765,0.0099530590316974,IL1A
230,KEGG_2021_Human,Tryptophan metabolism,1/42,0.9662690979939322,0.9999949078281076,0,0,0.2900674355580765,0.0099530590316974,ALDH8A1
231,KEGG_2021_Human,Necroptosis,7/159,0.9673455404302044,0.9999949078281076,0,0,0.5465091473820739,0.0181438386129084,H2AC11;H2AC12;IL1A;H2AC8;PLA2G4B;ALOX15;MACROH2A2
232,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,0.9674433711268104,0.9999949078281076,0,0,0.5801912761151892,0.0192033953481206,GNGT1;CDK6;CALML5;LEF1;CD200R1L;CALML3;CXCL1;HRAS;MAPK12
233,KEGG_2021_Human,Fatty acid degradation,1/43,0.9688868822437116,0.9999949078281076,0,0,0.2831456872154546,0.0089495019660514,ADH7
234,KEGG_2021_Human,Spinocerebellar ataxia,6/143,0.9695575310101868,0.9999949078281076,0,0,0.5198139939732533,0.0160702914162829,DAB1;PSMD2;MYOD1;PPIF;SLC1A6;GRM1
235,KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.9713016116823252,0.9999949078281076,0,0,0.2765458806562105,0.0080525291223205,DYNC1I1
236,KEGG_2021_Human,Insulin resistance,4/108,0.9718926728606172,0.9999949078281076,0,0,0.4567338810057256,0.0130214370393182,SLC2A1;SLC27A6;PPARGC1B;PRKAG3
237,KEGG_2021_Human,NOD-like receptor signaling pathway,8/181,0.973803028012894,0.9999949078281076,0,0,0.5484915207826162,0.0145603797365322,NLRP7;DEFA5;CARD18;PYDC1;PYDC2;CXCL1;DEFB4A;MAPK12
238,KEGG_2021_Human,Lipid and atherosclerosis,10/215,0.9739890524469996,0.9999949078281076,0,0,0.5783292920648505,0.0152419929431903,VAV3;CALML5;MMP1;MMP3;APOA1;CALML3;CXCL1;HRAS;SELE;MAPK12
239,KEGG_2021_Human,Amphetamine addiction,2/69,0.9740900881027664,0.9999949078281076,0,0,0.3547356945074241,0.009312339365723,CALML5;CALML3
240,KEGG_2021_Human,Proteasome,1/46,0.9755836499396028,0.9999949078281076,0,0,0.2642262417456216,0.0065315066985374,PSMD2
241,KEGG_2021_Human,Nucleotide excision repair,1/47,0.9774788766327412,0.9999949078281076,0,0,0.2584681496461072,0.0058875418023526,RFC4
242,KEGG_2021_Human,Endocytosis,12/252,0.9777832025348332,0.9999949078281076,0,0,0.59242029928432,0.0133100892231101,SH3GL3;ACAP2;TFRC;GRK7;WIPF3;CLTCL1;PARD6G;PLD1;HRAS;FGFR3;AP2M1;FGFR2
243,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,10/219,0.9780488318953946,0.9999949078281076,0,0,0.5671364304789974,0.0125879786310732,CCNB2;CCNA1;DLG1;CCND2;IL1R2;SLC2A1;BUB1B;ADCY2;ADCY8;HRAS
244,KEGG_2021_Human,Non-small cell lung cancer,2/72,0.9789165195932598,0.9999949078281076,0,0,0.3394773293932958,0.0072338922621266,CDK6;HRAS
245,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.979227065554834,0.9999949078281076,0,0,0.2529550827423167,0.0053099640729002,HMGCS1
246,KEGG_2021_Human,Oxidative phosphorylation,5/133,0.980003610986895,0.9999949078281076,0,0,0.4635635929404145,0.0093635315106459,ATP4B;ATP4A;COX8C;NDUFA4L2;COX6B2
247,KEGG_2021_Human,Inositol phosphate metabolism,2/73,0.9803223770261048,0.9999949078281076,0,0,0.3346777497564573,0.0066513204243997,IPPK;PLCH2
248,KEGG_2021_Human,Phagosome,6/152,0.9806134453174046,0.9999949078281076,0,0,0.4875309617450439,0.0095443636754292,TUBB6;TFRC;NOS1;PLA2R1;DYNC1I1;MBL2
249,KEGG_2021_Human,Malaria,1/50,0.9823270496791172,0.9999949078281076,0,0,0.2426040183515266,0.0043258677860798,SELE
250,KEGG_2021_Human,N-Glycan biosynthesis,1/50,0.9823270496791172,0.9999949078281076,0,0,0.2426040183515266,0.0043258677860798,ALG3
251,KEGG_2021_Human,Non-alcoholic fatty liver disease,6/155,0.9833752685376544,0.9999949078281076,0,0,0.477636609585615,0.0080073261671018,IL1A;COX8C;NDUFA4L2;COX6B2;PRKAG3;MAPK12
252,KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.9840155089763036,0.9999949078281076,0,0,0.321057321057321,0.0051733959584654,CDK6;HRAS
253,KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.985089558131437,0.9999949078281076,0,0,0.3167593191122603,0.0047585865528231,CLTCL1;WASF1
254,KEGG_2021_Human,Human immunodeficiency virus 1 infection,9/212,0.9859816576305652,0.9999949078281076,0,0,0.5253406691830337,0.0074165112711916,GNGT1;CCNB2;CALML5;CALML3;HRAS;APOBEC3A;PAK5;MAPK12;APOBEC3B
255,KEGG_2021_Human,Autoimmune thyroid disease,1/53,0.9861319497778592,0.9999949078281076,0,0,0.2285703637447823,0.0031920102790471,TG
256,KEGG_2021_Human,RNA degradation,2/79,0.9870310092591212,0.9999949078281076,0,0,0.308498224464611,0.0040270810184082,BTG4;PNLDC1
257,KEGG_2021_Human,Tuberculosis,7/180,0.9881944446921972,0.9999949078281076,0,0,0.4796188419813619,0.0056958546759528,IL1A;CALML5;NOS2;SPHK1;CALML3;PLA2R1;MAPK12
258,KEGG_2021_Human,B cell receptor signaling pathway,2/81,0.9887252650019646,0.9999949078281076,0,0,0.3006554130902604,0.0034090645764699,VAV3;HRAS
259,KEGG_2021_Human,Pyrimidine metabolism,1/56,0.9891179622930438,0.9999949078281076,0,0,0.2160676532769556,0.0023641431554198,UCK2
260,KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.9892885164170484,0.9999949078281076,0,0,0.3525546603819502,0.0037967543906862,EDAR;EDARADD;CXCL1
261,KEGG_2021_Human,Legionellosis,1/57,0.98996294786536,0.9999949078281076,0,0,0.2121977667035806,0.0021406007695583,CXCL1
262,KEGG_2021_Human,Huntington disease,14/306,0.9904165728190272,0.9999949078281076,0,0,0.5671902190888403,0.0054618397378524,COX8C;GPX2;DNAH17;NDUFA4L2;UCP1;CACNA1B;COX6B2;TUBB6;KLC3;PSMD2;CLTCL1;PPIF;HAP1;AP2M1
263,KEGG_2021_Human,Prion disease,12/273,0.990722255581604,0.9999949078281076,0,0,0.54412611521175,0.0050718271364699,IL1A;COX8C;TUBB6;KLC3;PSMD2;C9;NDUFA4L2;PPIF;CACNA1B;COX6B2;RYR3;MAPK12
264,KEGG_2021_Human,Ribosome biogenesis in eukaryotes,3/108,0.9917105148331568,0.9999949078281076,0,0,0.3390500831639253,0.0028222644232026,FBL;LSG1;FBLL1
265,KEGG_2021_Human,MicroRNAs in cancer,14/310,0.9918662273823168,0.9999949078281076,0,0,0.5594022361123339,0.0045686560860746,NOTCH3;ABCC1;WNT3A;CDCA5;KIF23;HOXD10;SERPINB5;CDC25A;CCND2;CDK6;FSCN1;HRAS;FGFR3;TP63
266,KEGG_2021_Human,Human cytomegalovirus infection,9/225,0.9923730875973924,0.9999949078281076,0,0,0.4933712121212121,0.0037773220496802,GNGT1;CDK6;CALML5;EIF4EBP1;CALML3;ADCY2;ADCY8;HRAS;MAPK12
267,KEGG_2021_Human,Amyotrophic lateral sclerosis,17/364,0.993073733158419,0.9999949078281076,0,0,0.5789422201488326,0.0040238596076937,COX8C;GPX2;DNAH17;NOS2;NDUFA4L2;NRG1;COX6B2;MAPK12;TUBB6;KLC3;NRG4;PSMD2;NEFL;NEFM;HAP1;NOS1;PFN2
268,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.993588929789146,0.9999949078281076,0,0,0.2728900578799159,0.0017551495453979,HRAS;MAPK12
269,KEGG_2021_Human,Lysine degradation,1/63,0.9938203718931058,0.9999949078281076,0,0,0.1915999833291656,0.0011876901753872,COLGALT2
270,KEGG_2021_Human,Yersinia infection,4/137,0.9948913175120032,0.9999949078281076,0,0,0.3565807723191473,0.0018263269916958,VAV3;WIPF3;CD8B2;MAPK12
271,KEGG_2021_Human,Measles,4/139,0.995479308177449,0.9999949078281076,0,0,0.3512597387031044,0.001591537169499,IL1A;CCND2;CDK6;TP73
272,KEGG_2021_Human,Ubiquitin mediated proteolysis,4/140,0.9957482410839882,0.9999949078281076,0,0,0.3486579097658481,0.0014855697614379,AIRE;UBE2S;KLHL13;SKP2
273,KEGG_2021_Human,Mitophagy,1/68,0.995875126404142,0.9999949078281076,0,0,0.1772532685410158,0.0007326594319297395,HRAS
274,KEGG_2021_Human,Diabetic cardiomyopathy,7/203,0.9964200127572362,0.9999949078281076,0,0,0.4228043357420789,0.0015163500073891,COX8C;NDUFA4L2;PPIF;SLC2A1;COX6B2;GAPDH;MAPK12
275,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.9964909464596252,0.9999949078281076,0,0,0.172096768153391,0.0006049588118587311,MAPK12
276,KEGG_2021_Human,Shigellosis,9/246,0.997280360690616,0.9999949078281076,0,0,0.4491369390103567,0.0012231544991001,H3C8;H3C15;MYL7;H3C1;WASF1;H3C7;HK2;MAPK12;PFN2
277,KEGG_2021_Human,Salmonella infection,9/249,0.9976630973658016,0.9999949078281076,0,0,0.4434496753246753,0.0010375114687593,TUBB6;KLC3;MYL7;LEF1;HRAS;GAPDH;DYNC1I1;MAPK12;PFN2
278,KEGG_2021_Human,Lysosome,3/128,0.9977680110880904,0.9999949078281076,0,0,0.2844915912031048,0.0006356917697886098,CLTCL1;CTSV;AP3B2
279,KEGG_2021_Human,Antigen processing and presentation,1/78,0.9981619913895662,0.9999949078281076,0,0,0.1541494681029565,0.00028358874885834186,CD8B2
280,KEGG_2021_Human,Th17 cell differentiation,2/107,0.9982388685255535,0.9999949078281076,0,0,0.2258872779881183,0.0003981679109652952,IL1RAP;MAPK12
281,KEGG_2021_Human,Peroxisome,1/82,0.9986695948296008,0.9999949078281076,0,0,0.1465052477111047,0.00019504110968318825,NOS2
282,KEGG_2021_Human,Epstein-Barr virus infection,6/202,0.9987418951342428,0.9999949078281076,0,0,0.3621688467998994,0.000455933254484055,CCNA1;CCND2;CDK6;PSMD2;SKP2;MAPK12
283,KEGG_2021_Human,Hepatitis B,4/162,0.9989284867031964,0.9999949078281076,0,0,0.2997501126541313,0.0003213584321073618,CCNA1;BIRC5;HRAS;MAPK12
284,KEGG_2021_Human,Coronavirus disease,7/232,0.99927484820035,0.9999949078281076,0,0,0.3677244559734832,0.000266752780847473,MMP1;C9;RPL10L;MMP3;RPL3L;MAPK12;MBL2
285,KEGG_2021_Human,Influenza A,4/172,0.9994358453814418,0.9999949078281076,0,0,0.2817537370935429,0.0001589975258898443,IL1A;CDK6;CPSF4L;TMPRSS11D
286,KEGG_2021_Human,Osteoclast differentiation,2/127,0.9995907401485684,0.9999949078281076,0,0,0.1895384615384615,7.758636018410116e-05,IL1A;MAPK12
287,KEGG_2021_Human,Toll-like receptor signaling pathway,1/104,0.9997735701643876,0.9999949078281076,0,0,0.1150748852261609,2.605933776202143e-05,MAPK12
288,KEGG_2021_Human,Autophagy,2/137,0.9998032674415104,0.9999949078281076,0,0,0.1754028106969283,3.451083852879553e-05,IRS4;HRAS
289,KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.9998802552368768,0.9999949078281076,0,0,0.2111786176307521,2.5289047690601683e-05,LMAN1L;HSPA4L;CRYAB
290,KEGG_2021_Human,RNA transport,3/186,0.9999561065729696,0.9999949078281076,0,0,0.1937098381863296,8.502775256834758e-06,FXR1;EIF4EBP1;THOC3
291,KEGG_2021_Human,Ribosome,2/158,0.999956369668317,0.9999949078281076,0,0,0.1516168597616561,6.615238193699952e-06,RPL10L;RPL3L
292,KEGG_2021_Human,Spliceosome,1/150,0.999991208926554,0.9999949078281076,0,0,0.0793489759464474,6.975657415888078e-07,THOC3
293,KEGG_2021_Human,Herpes simplex virus 1 infection,3/498,0.9999949078281076,0.9999949078281076,0,0,0.0703908424477635,3.5844318201310373e-07,EIF4EBP1;ZNF556;NECTIN1
